TSE:MFC

Manulife Financial (MFC.TO)

61.06
+0.02 (0.03%)
as of Aug 12, 2026, 8:00:00 pm Market Open.
1631 watching
0
Investor Insights
star iconAug 12, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has shown solid performance recently, particularly in Asia, where it benefits from healthy growth and a stable business in wealth management. However, there is concern over potential government-imposed taxes on its products in mainland China. While the stock has performed well, analysts caution that it is currently feeling somewhat overbought, trading at a price-to-earnings ratio above its historical levels, and advise investors to be selective. Consensus analysis suggests good long-term potential due to its decent dividend yield and solid execution in asset management, even as financial conditions such as interest rates fluctuate. Overall, MFC is viewed as a reliable income stock, with room for growth despite being traded at attractive valuations compared to Canadian banks.

consensus icon
Consensus
Positive
valuation icon
Valuation
Fair Value
review icon
Similar
SLF
TOP PICK
One of largest lifecos in the world. Asia counts for 35% of revenue, with greater demand in the future. Growing middle class and aging demographic are a bonus. At 1x price to book, trades at a discount to the peer group. Interest rates will benefit. Yield is 4.59%. (Analysts’ price target is $29.22)
BUY
All insurers have suffered from the flat yield curve. Bond yields picking up is bullish for all financials. It's been in the penalty box since the financial crisis and a few stumbles. Getting paid to wait. Good risk/reward. Has to prove that it can deliver and execute as SLF does.
BUY
Really likes it. Not expensive multiple. Likes the Asian franchise. Asset management has done well. Hurt by low interest rates. Stable.
HOLD
Last quarter was disappointing. Great expansion into Asia. Recent drop in yields has hurt all the financials. Dividend yield, growth, safety. Not everything in your portfolio fires at the same time. Some things you just tuck away and wait. Good company, growing. Yield is 4-5%, better than cash or bonds.
PAST TOP PICK
(A Top Pick Jul 17/20, Up 34%) There is no reason to sell it. The shares remain cheap and offer an excellent yield. They offer good upside potential.
HOLD
Massive investment in Asia is one of the positives. Long-term opportunity is good. Interest rate sensitivity of the lifecos can have a magnified effect the stock price. As a long-term investor, don't worry about this.
TOP PICK
Goes back to the caution on broader market. Has not seen a big run like other stocks. Yields over 4% at current levels and could increase it. Continued growth trends. Collect your dividend while you are in a stable entity and wait for upside. Good for when things look frothy. (Analysts’ price target is $29.02)
PAST TOP PICK
(A Top Pick Jun 05/20, Up 31%) They have had a great run. The company has underlying good things happening. Looking for better days.
HOLD

Likes it and a lot of the insurers. A good long-term name, though he owns SLF and GWO instead. Expects dividend to increase over time by 8-10% yearly. Pullback due to interest rates coming down. Rates will probably move higher 12-24 months out. Asia exposure is a growing segment. Yield is 4%.

HOLD
It is the most discounted insurance company in Canada. It is trading at this level because it has been the performance laggard for quite some time. It has become a show-me story. However if you were going to buy an insurance company, this would be the one to buy. There is the chance of a bounce back or a trading opportunity. It has a decent dividend while you wait for an uptick.
BUY ON WEAKNESS
Would hold and it is getting close to adding back to it. They are one of the biggest at risk plays of interest rates going down. They are geared to benefit from higher interest rates. Moves out of financials is hurting their stock price. Would add on weakness.
TOP PICK
Canada's largest lifeco. Geographically diversified. Asia is demographically advantaged. The US business is lagging, but they're working on this. Canadian business is steady-eddy. Investing relentlessly in tech. Stock is inexpensive. Yield is 4.44%. (Analysts’ price target is $28.83)
BUY
The most volatile of Canadian lifecos, because it has the greatest difference between reported earnings and core earnings due to having a ton of both market and interest rate exposure. Likes it. Nice franchise in the US and Asian exposure to the emerging consumer. It's done increasingly well the last 10 years.
BUY

Interesting, likes the name. Perhaps management doesn't pay out more to shareholders or buy back shares because they want to expand or keep cash on hand. Doing well. Will benefit long-term from growth in Asia. 7-8x forward earnings, with 7-9% earnings growth going forward. Revenues and earnings will grow. He owns SLF and GWO instead. Yield of 4.5%.

BUY

Banks or lifecos? She likes both sectors, so it's not an either-or question. Banks will benefit from the reopening/recovery. She expects earnings upside and revisions probably later this year. Bank stocks have had a nice rally this year, but long term they remain attractive given their yields. The lifecos' valuations remain good, and wealth management offers key growth. She likes MFC's presence in Asia for its strong long-term growth. She owns TD, Royal and BNS.

Showing 241 to 255 of 2,284 entries